| Phase 4 |
| NCT06979726 |
Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening… |
Heart Failure |
Recruiting |
2026-06-08 |
| NCT06821191 |
Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching… |
Coronary Artery Disease |
Recruiting |
2026-05-12 |
| NCT07225842 |
The Bridging Antiplatelet Therapy With Cangrelor 2 Study |
Coronary Arterial Disease (CAD) |
Recruiting |
2026-05-05 |
| NCT06046859 |
Can Immediate Post-injury Fluoxetine Improve the Recovery Trajectories of Victims in… |
Musculoskeletal Injury |
Recruiting |
2026-04-13 |
| NCT05681702 |
Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI |
Coronary Artery Disease |
Recruiting |
2026-03-09 |
| NCT06246396 |
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension |
Hypertension, Resistant to Conventional Therapy |
Recruiting |
2026-03-06 |
| NCT06588595 |
The Switching Antiplatelet-9 (SWAP-9) Study |
Coronary Arterial Disease (CAD) |
Recruiting |
2026-02-25 |
| NCT06228456 |
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective… |
Coronary Artery Disease |
Recruiting |
2026-02-05 |
| NCT06691191 |
Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors |
Coronary Artery Disease |
Recruiting |
2026-02-05 |
| NCT07025148 |
Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel… |
Coronary Arterial Disease (CAD) |
Recruiting |
2025-11-04 |
| NCT04331704 |
ANCHORS Alcohol & Sexual Health Study: UH3 Project |
Alcohol Use, Unspecified |
Recruiting |
2025-07-10 |
| NCT07843264 |
PPI Dosing Per CYP2C19 Genotype |
Gastroesophageal Reflux Disease With Esophagitis |
Not Yet Recruiting |
2026-09-28 |
| NCT03632044 |
Evaluation of Trigeminal Nerve Blockade |
Mouth Abnormalities |
Active, Not Recruiting |
2026-07-21 |
| Phase 3 |
| NCT05047172 |
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular… |
Intracranial Arteriosclerosis |
Active, Not Recruiting |
2026-09-25 |
| NCT07670650 |
PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide… |
Type 1 Diabetes (T1D) |
Not Yet Recruiting |
2026-06-26 |
| Phase 2/3 |
| NCT07507214 |
Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation… |
Concussion |
Not Yet Recruiting |
2026-08-18 |
| NCT05195775 |
Tadalafil as Adjuvant Therapy for DMD |
Duchenne Muscular Dystrophy |
Active, Not Recruiting |
2025-02-27 |
| Phase 2 |
| NCT06558214 |
OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser… |
Recurrent Glioblastoma |
Recruiting |
2026-09-23 |
| NCT06184516 |
Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy |
Urothelial Carcinoma Bladder |
Recruiting |
2026-09-09 |
| NCT06327490 |
A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing… |
Breast Cancer |
Recruiting |
2026-09-09 |
| NCT05669339 |
AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma |
Hepatocellular Carcinoma |
Recruiting |
2026-07-14 |
| NCT06008795 |
BLOCK-SAH - PPF-Block for Post-SAH Headache |
Subarachnoid Hemorrhage, Aneurysmal |
Recruiting |
2026-07-06 |
| NCT06402357 |
High Intensity Focused Ultrasound in Prostate Cancer |
Prostate Cancer |
Recruiting |
2026-06-08 |
| NCT07107334 |
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in… |
Endometrioid Endometrial Adenocarcinoma |
Recruiting |
2026-06-08 |
| NCT05800210 |
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in… |
Acute Lymphoblastic Leukemia |
Recruiting |
2026-06-04 |